Assignment of Assignor's Interest

Recorded: 2017-04-04 Pages: 5

Assignor

RAQUALIA PHARMA INC.

Executed: 2017-03-16

Assignee

ASKAT INC.

4-37-2 HIROJIHONMACHI SHOWA-KU, NAGOYA, 466-0841, JAPAN

Covered Properties (2)

Selective EP4 Receptor Antagonistic Substance for Treatment of Cancer

Patent: 8,921,391 →

Application: 13/265,216 →

Publication: US 2012/0088723

Selective EP4 Receptor Antagonistic Substance for Treatment of Cancer

Patent: 9,688,674 →

Application: 14/547,247 →

Publication: US 2015/0111920

Related Assignments (1)

Other recorded transfers of the patents in this record — the chain of ownership.